LGC announces changes to its Executive Leadership Team
These changes follow recent strong trading performance and further strategy endorsement by Cinven and Astorg, LGC’s new shareholders.
Read MoreNews
To contact the press office please email or call +44 7408 850 514
LGC scientists support investigations into unlicensed ‘medicines’
LGC’s Teddington-based Medicines Testing Team supported the MHRA investigation in 2015, testing samples (all of which proved negative) for the presence of vitamin D2.
Read MoreOliX Pharmaceuticals signs agreement with LGC to accelerate production of asymmetric siRNA for the treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration
LGC will produce active pharmaceutical ingredients for preclinical and clinical study of OLX301D programme.
Read MoreHow does standardization protect the environment?
Through our development of manufacturing and reference materials, studies on standardization, and genomics work, we enable scientists to better understand the impact of human activities.
Read MoreLGC expands SARS-CoV-2 offering to include serology quality solutions
Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence
Read MoreNML at LGC joins more than 500 scientists in 18 countries to map COVID-19 effects and treatments in patients’ blood
Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement.
Read MoreNew National Measurement System customer survey results published
The NMS is the nation’s technical infrastructure underpinning trade, industry and regulation, and plays a vital role in supporting innovation and growth in the UK and delivers services to underpin the certification of calibration.
Read MoreCOVID-19: How the National Measurement Laboratory supports standards to fight COVID19
This World Metrology Day, the National Measurement Laboratory at LGC celebrates the work of our metrologists during the current COVID-19 pandemic.
Read MoreLGC working closely with customers and partners to expedite detection solutions
Working together on supply of a SARS-CoV-2 assay for laboratory use which delivers a result in approximately 70 minutes.
Read MoreLGC’s innovative SARS-CoV-2 Quality Solutions now includes S gene
Offers expanded genome coverage to include S gene region
Read MoreLGC’s ValuPanel reagents help public laboratories detect SARS-CoV-2 virus
Charité reagents are part of the ValuPanel line of detection reagents and composed of probes and primers that resolve genetic signatures of different pathogen
Read MoreBolstering COVID diagnostics and research by reducing risks of contamination
We support scientists on the front line of human healthcare with our custom manufacturing of components for (q)PCR- and NGS-based diagnostics.
Read More